Cargando…
En1 and Wnt signaling in midbrain dopaminergic neuronal development
Dopaminergic neurons of the ventral mesodiencephalon are affected in significant health disorders such as Parkinson's disease, schizophrenia, and addiction. The ultimate goal of current research endeavors is to improve the clinical treatment of such disorders, such as providing a protocol for c...
Autores principales: | Alves dos Santos, Maria TM, Smidt, Marten P |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3104484/ https://www.ncbi.nlm.nih.gov/pubmed/21569278 http://dx.doi.org/10.1186/1749-8104-6-23 |
Ejemplares similares
-
Acquisition of the Midbrain Dopaminergic Neuronal Identity
por: Mesman, Simone, et al.
Publicado: (2020) -
WNT signaling in midbrain dopaminergic neuron development and cell replacement therapies for Parkinson’s disease
por: Arenas, Ernest, et al.
Publicado: (2015) -
Mesodiencephalic Dopaminergic Neuronal Differentiation Does Not Involve GLI2A-Mediated SHH-Signaling and Is under the Direct Influence of Canonical WNT Signaling
por: Mesman, Simone, et al.
Publicado: (2014) -
Molecular Programming of Mesodiencephalic Dopaminergic Neuronal Subsets
por: Smidt, Marten P.
Publicado: (2017) -
Development and Differentiation of Midbrain Dopaminergic Neuron: From Bench to Bedside
por: Wang, Mengmeng, et al.
Publicado: (2020)